_sf3b1-as-therapeutic-target-in-flt3-itd-positive-aml-preview-1.jpg "SF3B1 as therapeutic target in FLT3 ITD positive AML from flt3 itd mutation positive Video Screenshot Preview 1")
Gallery_sf3b1-as-therapeutic-target-in-flt3-itd-positive-aml-preview-3.jpg "SF3B1 as therapeutic target in FLT3 ITD positive AML from flt3 itd mutation positive Video Screenshot Preview 3")
Gallery_sf3b1-as-therapeutic-target-in-flt3-itd-positive-aml-preview-hqdefault.jpg "SF3B1 as therapeutic target in FLT3 ITD positive AML from flt3 itd mutation positive Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 1 minute 40 seconds
👁 View: 37 times
Play Audio:👁 View: 37 times
Description:
VJHemOnc – Video Journal of Hematology u0026 HemOnc
VJHemOnc – Video Journal of Hematology u0026 HemOnc
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_aml17-trial-update-flt3-itd-mutation-and-daunorubicin-dosage.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_quizartinib-advances-overall-survival-in-acute-myeloid-leukaemia-patients.webp "Dr Harry Erba speaks to ecancer at the EHA 2022 meeting about quizartinib improving the overall survival in adult patients with FLT3-ITD+ acutenmyeloid leukaemia.nn Acute myeloid leukaemia (AML) is the most common acute leukaemia in adults, and approximately 25% of all newly diagnosed cases carry the FLT3-internal tandem duplication (ITD) gene mutation.nnThe results showed that the addition of quizartinib significantly improved overall survival compared with standard induction and consolidation")
⏲ 2 min 14 sec ✓ 11-Jun-2022
_what-is-flt3-mutated-acute-myeloid-leukemia.webp "Patient Empowerment Network")
_dr-rllig-on-flt3-itd-npm1-mutation-status-for-patients-with-aml.webp "Targeted Oncology")
_prognostic-impact-of-flt3-itd-in-older-patients-with-aml.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_midostaurin-in-c-kit-or-flt3-itd-mutated-t821-aml.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_tangible-benefit-for-flt3-itd-r-r-aml-on-quizartinib.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_the-2021-treatment-algorithm-for-flt3-mutated-aml.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_aml17-trial-update-flt3-itd-mutation-and-daunorubicin-dosage.jpg)
_quizartinib-advances-overall-survival-in-acute-myeloid-leukaemia-patients.jpg)
_what-is-flt3-mutated-acute-myeloid-leukemia.jpg)
_dr-rllig-on-flt3-itd-npm1-mutation-status-for-patients-with-aml.jpg)
_prognostic-impact-of-flt3-itd-in-older-patients-with-aml.jpg)
_midostaurin-in-c-kit-or-flt3-itd-mutated-t821-aml.jpg)
_tangible-benefit-for-flt3-itd-r-r-aml-on-quizartinib.jpg)
_the-2021-treatment-algorithm-for-flt3-mutated-aml.jpg)
![[+]](/images/menu.gif){kind=small}